Abstract
Two Japanese chemical companies are increasing their presence in the active pharmaceutical ingredient (API) business. Sumitomo Chemical says it will build a third plant in Japan—this one in Oita City—for small-molecule APIs and intermediates. The firm says the project will enhance its leading position in Japan. Meanwhile, AGC says it will spend $100 million to expand its small-molecule API plant in Malgrat de Mar, Spain. AGC acquired the facility in 2019.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
